Bruker | BRKR - Current Liabilities


Bruker reported $1.17B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
ABB USD 19.4B 959M Sep/2026
Agilent USD 2.29B 20M Jun/2026
Ametek USD 2.64B 20.37M Sep/2026
Bio Techne USD 361.27M 197.57M Sep/2026
Bio-Rad Laboratories USD 969.1M 7.8M Sep/2026
Bruker USD 1.17B 32.6M Sep/2026
Charles River Laboratories USD 1.09B 45.49M Sep/2026
Danaher USD 9.05B 945M Sep/2026
Fujikura JPY 358.5B 16.77B Sep/2026
Furukawa JPY 71.78B 24.74B Jun/2026
General Electric Aerospace USD 42.4B 1.96B Sep/2026
Hitachi JPY 7.34T 175.94B Sep/2026
Illumina USD 1.16B 422M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
Mettler Toledo International USD 1.25B 49.81M Sep/2026
Mitsubishi Electric JPY 2.11T 17.74B Sep/2026
Mitsubishi Heavy Industries JPY 4.27T 74.8B Sep/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Nikon Corporation JPY 302.25B 39.74B Sep/2026
Olympus JPY 391.7B 75.68B Sep/2026
Repligen USD 125.69M 6.97M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
Smiths GBP 1.35B 344M Dec/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Waters USD 2.4B 126M Jun/2026